ABSTRACT A 3‐year‐old, intact female Havanese dog was presented for treatment of a relapse of suspected immune‐mediated anemia and thrombocytopenia. Over the course of treatment, the patient's anemia appeared to acutely transition from macrocytic and hypochromic to microcytic and hypochromic between days five and six of hospitalization.
Hannah R. Cohen +5 more
wiley +1 more source
Eltrombopag for Refractory Immune Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: A Case Report. [PDF]
Alsalman M.
europepmc +1 more source
Management of Refractory Immune Thrombocytopenia with Fostamatinib: A Case Report [PDF]
Khutaija Noor, Henna Qadri, Atif Hussein
openalex +1 more source
Abstract figure legend Endothelial specific molecule‐1 (ESM‐1) and guanylate binding protein‐1 (GBP‐1) are proteins that are produced by activated/dysfunctional endothelial cells and are increased and decreased, respectively, during preeclampsia. It remains to be established whether ESM‐1 and GBP‐1 could potentially be included as biomarkers for the ...
Ines Pronk +3 more
wiley +1 more source
Immune Thrombocytopenia and Type 1 von Willebrand Disease in a Patient With a Femoral Fracture: A Case Report. [PDF]
Ferreira A, Roberto A.
europepmc +1 more source
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors [PDF]
Rebecca Karp Leaf +42 more
openalex +1 more source
A Case of Severe Refractory Immune Thrombocytopenia Exacerbated by Respiratory Syncytial Virus Infection. [PDF]
Kim J +4 more
europepmc +1 more source
Current Trends in Duchenne Muscular Dystrophy Research and Therapy: 3D Cardiac Modelling
ABSTRACT Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, presents a multifaceted challenge that affects both skeletal muscle function and cardiomyocyte homeostasis, causing progressive degeneration and life‐threatening cardiac complications by adolescence.
Marta Przymuszała +3 more
wiley +1 more source
Thrombocytopenia, immune thrombocytopenia and idiopathic thrombocytopenic purpura
Sinasi Ozsoylu
doaj
Rilzabrutinib for the Treatment of Immune Thrombocytopenia. [PDF]
Labanca C +12 more
europepmc +1 more source

